Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
| Actual shortage: | 54 (12%) | |
| Anticipated shortage: | 15 (3%) | |
| Avoided shortage: | 8 (2%) | |
| Resolved: | 368 (83%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
12 (16%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RISEDRONATE | 35MG | TABLET | Resolved | 2023-03-16 | 2024-02-29 | 187292 |
| MIRTAZAPINE | 30MG | TABLET | Resolved | 2023-03-16 | 2023-05-04 | 187300 |
| MIRTAZAPINE | 30MG | TABLET | Resolved | 2023-07-05 | 2024-01-30 | 197632 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2018-10-01 | 2018-10-31 | 62786 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2019-04-26 | 2019-06-04 | 82512 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2019-06-10 | 2019-11-28 | 86038 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2020-03-10 | 2021-07-08 | 108347 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2018-10-01 | 2018-10-31 | 62789 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2020-03-10 | 2021-02-10 | 108341 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2023-06-27 | 2023-11-13 | 196716 |
| IRBESARTAN | 300MG | TABLET | Resolved | 2020-03-10 | 2021-09-14 | 108344 |
| IRBESARTAN | 300MG | TABLET | Resolved | 2023-10-23 | 2024-02-29 | 207903 |
| OLANZAPINE | 15MG | TABLET | Resolved | 2023-07-17 | 2023-09-05 | 198789 |
| IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Resolved | 2020-01-20 | 2020-03-04 | 103707 |
| IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Resolved | 2020-03-10 | 2020-10-21 | 108338 |
| IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Resolved | 2020-01-20 | 2021-09-14 | 103710 |
| IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2018-03-07 | 2018-04-13 | 42112 |
| IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2018-08-14 | 2018-09-05 | 58073 |
| IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2019-01-28 | 2019-04-09 | 73693 |
| IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2020-03-10 | 2021-09-14 | 108350 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-04-08 | 2020-06-13 | 111515 |
| MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
| MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
| BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |